• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Suez Canal University Medical Journal
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 28 (2025)
Volume Volume 27 (2024)
Volume Volume 26 (2023)
Volume Volume 25 (2022)
Volume Volume 24 (2021)
Volume Volume 23 (2020)
Volume Volume 22 (2019)
Volume Volume 21 (2018)
Volume Volume 20 (2017)
Volume Volume 19 (2016)
Issue Issue 2
Issue Issue 1
Volume Volume 18 (2015)
Volume Volume 17 (2014)
Volume Volume 16 (2013)
Volume Volume 15 (2012)
Volume Volume 14 (2011)
Volume Volume 13 (2010)
Abdel Aleem, A., Attia, F., Omar, A., Hassan, R. (2016). Clinical Significance of Foxp3 Gene Expression in Patients with Lupus Nephritis. Suez Canal University Medical Journal, 19(2), 193-200. doi: 10.21608/scumj.2016.116297
Amaal Abdel Aleem; Fadia Attia; Aziza Omar; Ranya Hassan. "Clinical Significance of Foxp3 Gene Expression in Patients with Lupus Nephritis". Suez Canal University Medical Journal, 19, 2, 2016, 193-200. doi: 10.21608/scumj.2016.116297
Abdel Aleem, A., Attia, F., Omar, A., Hassan, R. (2016). 'Clinical Significance of Foxp3 Gene Expression in Patients with Lupus Nephritis', Suez Canal University Medical Journal, 19(2), pp. 193-200. doi: 10.21608/scumj.2016.116297
Abdel Aleem, A., Attia, F., Omar, A., Hassan, R. Clinical Significance of Foxp3 Gene Expression in Patients with Lupus Nephritis. Suez Canal University Medical Journal, 2016; 19(2): 193-200. doi: 10.21608/scumj.2016.116297

Clinical Significance of Foxp3 Gene Expression in Patients with Lupus Nephritis

Article 10, Volume 19, Issue 2, October 2016, Page 193-200  XML PDF (645.06 K)
Document Type: Original Article
DOI: 10.21608/scumj.2016.116297
View on SCiNiTO View on SCiNiTO
Authors
Amaal Abdel Aleem1; Fadia Attia1; Aziza Omar2; Ranya Hassan email 1
1Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Egypt
2Department of Rheumatology and Rehabilitation, Faculty of Medicine, Suez Canal University, Egypt
Abstract
Background: Lupus nephritis (LN) is an inflammation of the kidney that is one of the most seri-ous complications of SLE. Recent studies revealed that the Foxp3 plays an important role in the pathogenesis of SLE. Objectives: To measure Foxp3 mRNA expressions in peripheral blood of patients with active and inactive form of lupus nephritis (LN) versus healthy control subjects and explore its role in disease activity. Subjects and Methods: Real time PCR was used to detect the mRNA expression of Foxp3 by SYBR Green technique in the peripheral blood mononuclear cells (PBMNCs Foxp3) of 24 patients with active lupus nephritis (LN), 10 patients with inactive lupus and 40 healthy subjects. Results: We found that Foxp3 mRNA expression level in both patient groups (n=34) was significantly higher than that in normal control group (n=40), (p < 0.05). The mRNA expression of Foxp3 inactive stage (n=24) was higher than that in inactive stage (n=10), (p < 0.05). Moreover, Foxp3 mRNA level positively correlated with SLEDAI (r=0.592, p
Keywords
CD4+CD25+ Tregs; Foxp3 mRNA; SLE
Statistics
Article View: 189
PDF Download: 491
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.